Sign In
Buy MRT
$1.79
-0.0100 (-0.556%)
At Close: Jun 03, 2026
Marti Is Highly Risky, Financially And Operationally
03:24am, Wednesday, 03'rd Jun 2026
Marti Is Highly Risky, Financially And Operationally
Marti Technologies, Inc. (MRT) Q1 2026 Earnings Call Transcript
12:30pm, Thursday, 21'st May 2026
Marti Technologies, Inc. (MRT) Q1 2026 Earnings Call Transcript
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT) today announced its financial and operational results
Marti Technologies, Inc. to Report 2026 First Quarter Results on May 21, 2026
06:00am, Monday, 18'th May 2026
ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti”) (NYSE American: MRT), Türkiye's leading mobility super app, will announce its financial and operational results for the quarter ended
Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
07:00am, Thursday, 07'th May 2026
Interim clinical data from GFORCE-1 trial of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in subjects with elevated CVD risk; readout of expanded GFORCE-1 trial in subjects with ele
Morguard Real Estate Investment Trust (MRT.UN:CA) Q1 2026 Earnings Call Transcript
06:41pm, Friday, 01'st May 2026
Morguard Real Estate Investment Trust (MRT.UN:CA) Q1 2026 Earnings Call Transcript
Marti Announces a New Share Repurchase Program
06:00am, Monday, 27'th Apr 2026
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT) today announced a new share repurchase program. The Co
Marti Technologies, Inc. Files Annual Report on Form 20-F for Fiscal Year 2025
04:15pm, Wednesday, 15'th Apr 2026
ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye's leading mobility super app, announced that it has filed its annual report on For
Marti: A Potential Early-Stage Opportunity Has Emerged
08:27am, Wednesday, 15'th Apr 2026
Marti Technologies, Inc. (MRT) offers hyper-growth exposure to Turkey's e-hailing and mobility market, combining ride-hailing, delivery, and self-use fleet services. MRT's 2025 revenue grew 110.3% yea
Marti Technologies, Inc. (MRT) Q4 2025 Earnings Call Transcript
12:21pm, Monday, 13'th Apr 2026
Marti Technologies, Inc. (MRT) Q4 2025 Earnings Call Transcript
Marti Revenue Increases 110%, Delivers 61% Gross Profit Margin for Full-Year 2025
06:46am, Monday, 13'th Apr 2026
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT) today announced its financial and operational results
Marti Technologies, Inc. to Report 2025 Fiscal Year Results on April 13, 2026
05:00am, Friday, 10'th Apr 2026
ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti”) (NYSE American: MRT), Türkiye's leading mobility super app, will announce its financial and operational results for the fiscal year e
Marti's Ride-Hailing Service Reaches 3.80 Million Riders and 490 Thousand Registered Drivers, Exceeding March 31, 2026 Targets
06:39am, Wednesday, 18'th Mar 2026
ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye's leading mobility super app, announced today that as of March 17, 2026, Marti's r
Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
07:00am, Tuesday, 17'th Mar 2026
Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipat
Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment
